BIONIK LABORATORIES CORP. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-08-14: Reporting owner AUBERTON-HERVE ANDRE-JACQUES; Form 4; Security Warrant; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-14: Reporting owner Gaston-Dreyfus Remi; Form 4; Security Warrant; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-03-31: Reporting owner Gaston-Dreyfus Remi; Form 4; Security Warrant; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-03-31: Reporting owner Gaston-Dreyfus Remi; Form 4; Security Warrant; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-08-14 | AUBERTON-HERVE ANDRE-JACQUES Director | 4 | Warrant Derivative · Indirect · Warrants held through held through Star SCI | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600,640 1,600,640 owned after | $0.06 exercise price | 2018-04-03 | |
| 2017-08-14 | Gaston-Dreyfus Remi Director, 10% Owner | 4 | Warrant Derivative · Indirect · Warrants held through RGD Investissements | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,858,343 5,858,343 owned after | $0.06 exercise price | 2018-04-03 | |
| 2017-03-31 | Gaston-Dreyfus Remi Director, 10% Owner | 4 | Warrant Derivative · Indirect · Warrants held through RGD Investissements | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,760,704 3,361,344 owned after | $0.06 exercise price | 2018-04-03 | |
| 2017-03-31 | Gaston-Dreyfus Remi Director, 10% Owner | 4 | Warrant Derivative · Indirect · Warrants held through Lombard International Assurance SA | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600,640 3,361,344 owned after | $0.06 exercise price | 2018-04-03 |